{"disease":{"id":"household-contact","name":"household contact"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05118490","title":"Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"The Aurum Institute NPC","has_results":false},{"nct_id":"NCT04788407","title":"Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":456,"lead_sponsor_name":"Fundación Huésped","has_results":false},{"nct_id":"NCT04938596","title":"Airborne Preventive Measures to Reduce New TB Infections in Household Contacts","phase":"NA","overall_status":"COMPLETED","enrollment_count":432,"lead_sponsor_name":"Pontificia Universidad Catolica de Chile","has_results":false},{"nct_id":"NCT04543357","title":"A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.","phase":"","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Pfizer","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}